Resuscitation fluids in trauma, part II: Which fluid should I give?

Trauma

Volumn 8, Issue 2, 2006, Pages 111-121

  Vercueil, Andre ^a   Levett, Denny ^b   Grocott, Michael ^b  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN; DEXTRAN 40; DEXTRAN 70; DIASPIRIN CROSSLINKED HEMOGLOBIN; ELOHAES; GELATIN; GELATIN SUCCINATE; GLUCOSE; HETASTARCH; HUMAN SERUM ALBUMIN; ISOTONIC SOLUTION; LACTIC ACID; POLYGELINE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANAPHYLAXIS; ARTICLE; BLOOD CLOTTING; BLOOD TRANSFUSION; BODY FLUID; CLINICAL TRIAL; COLLOID; CRYSTALLOID; DRUG HALF LIFE; FLUID RESUSCITATION; FLUID TRANSPORT; HEART ARREST; HEMOSTASIS; HUMAN; INTRAVASCULAR SPACE; INTRAVENOUS ADMINISTRATION; MEDICAL DECISION MAKING; MORBIDITY; MORTALITY; MULTIPLE TRAUMA; OXYGEN TRANSPORT; RESPIRATORY ARREST; RESUSCITATION; RISK FACTOR; SURVIVAL; TOTAL BODY WATER;

EID: 34547861643     PISSN: 14604086     EISSN: None     Source Type: Journal    
DOI: 10.1177/1460408606071147     Document Type: Article

References (54)

1. Alderson P, Schierhout G, Roberts I, Bunn F. 2000. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2: CD000567–CD000567.
2. Allison KP, Gosling P, Jones S, Pallister I, Porter KM. 1999. Randomized trial of hydroxyethyl starch versus gelatine for trauma resuscitation. J Trauma 47: 1114–1121.
3. Balogh Z, McKinley BA, Cocanour CS et al. 2003. Supranormal trauma resuscitation causes more cases of abdominal compartment syndrome. Arch Surg 138: 637–642.
4. Baron JF. 1999. Blood substitutes. Haemoglobin therapeutics in clinical practice. Crit Care 3: R99–102.
5. Battle J, del Rio F, Lopez Fernandez MF et al. 1985. Effect of dextran on factor VIII/von Willebrand factor, structure and function. Thromb Haemost 54: 697–699.
6. Bunn F, Roberts I, Tasker R, Akpa E. 2002. Hypertonic versus isotonic crystalloid for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 1: CD002045-CD002045.
7. Bunn F, Alderson P, Hawkins V. 2004. Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev 1: CD001319–CD001319
8. Choi PT, Yip G, Quinonez LG, Cook DJ. 1999. Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med 27: 200–210.
9. Cooper DJ, Myles PS, McDermott FT et al. 2004. Prehospital hypertonic saline resuscitation of patients with hypotension and severe traumatic brain injury: a randomized controlled trial. JAMA 291: 1350–1357.
10. Cullen MJ, Singer M. 1990. Severe anaphylactoid reaction to hydroxyethyl starch. Anaesthesia 45: 1041–1042.
11. de Jonge E, Levi M. 2001. Effects of different plasma substitutes on blood coagulation: a comparative review. Crit Care Med 29: 1261–1267.
12. Deitch EA, Shi HP, Feketeova E, Hauser CJ, Xu DZ. 2003. Hypertonic saline resuscitation limits neutrophil activation after trauma-hemorrhagic shock. Shock 19: 328–333.
13. Dorman T, Breslow MJ. 1994. Altered immune function after trauma and hemorrhage: what does it all mean? Crit Care Med 22: 1069–1070.
14. Farrar D, Grocott M. 2003. Intravenous artificial oxygen carriers. Hosp Med 64: 352–356.
15. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R. 2004. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350: 2247–2256.
16. Freeman MK. 1979. Fatal reaction to haemaccel. Anaesthesia 34: 341–343.
17. Gan TJ, Bennett-Guerrero E, Phillips-Bute B et al. 1999. Hextend, a physiologically balanced plasma expander for large volume use in major surgery: a randomized phase III clinical trial. Hextend Study Group. Anesth Analg 88: 992–998.
18. Greaves I, Porter KM, Revell MP.2002. Fluid resuscitation in pre-hospital trauma care: a consensus view. J R Coll Surg Edinb 47(2): 451–457.
19. Grocott MP, Hamilton MA. 2002. Resuscitation fluids. Vox Sang 82(1): 1–8.
20. Grocott MPW, Mythen MG. 1999. Fluid therapy. In Goldhill DR and Strunin, eds, Bailliere's clinical anaesthesiology, 13(3). Harcourt Publishers Ltd, 363–381.
21. Haljamae H, Dahlqvist M, Walentin F. 1997. Artificial colloids in clinical practice: pros and cons. In Haljamäe H, eds, Bailliere's clinical anaesthesiology, 11. Harcourt Publishers Ltd, 49–79.
22. Hebert PC, Wells G, Blajchman MA et al. 1999. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 340: 409–417.
23. Hedin H, Richter W, Ring J. 1976. Dextran-induced anaphylactoid reactions in man: role of dextran reactive antibodies. Int Arch Allergy Appl Immunol 52: 145–159.
24. Karoutsos S, Nathan N, Lahrimi A, Grouille D, Feiss P, Cox DJ. 1999. Thrombelastogram reveals hypercoagu-lability after administration of gelatin solution. Br J Anaesth 82: 175–177.
25. Kramer GC. 2003. Hypertonic resuscitation: physiologic mechanisms and recommendations for trauma care. J Trauma 54 (5 Suppl): S89–S99.
26. Lamke LO, Liljedahl SO. 1976. Plasma volume changes after infusion of various plasma expanders. Resuscitation 5: 93–102.
27. Laubenthal H, Messmer K. 1992. Allergic reactions to dextrans. In Baron FJ ed. Plasma volume expansion. Arnette Blackwell.
28. Laxenaire MC, Charpentier C, Feldman L. 1994. [Anaphylactoid reactions to colloid plasma substitutes: incidence, risk factors, mechanisms. A French multicenter prospective study]. Ann Fr Anesth Reanim 13: 301–310.
29. Lorenz W, Doenicke A, Messmer K et al. 1976. Histamine release in human subjects by modified gelatin (Haemaccel) and dextran: an explanation for anaphylactoid reactions observed under clinical conditions? Br J Anaesth 48: 151–165.
30. Malone DL, Dunne J, Tracy JK, Putnam AT, Scalea TM, Napolitano LM. 2003. Blood transfusion, independent of shock severity, is associated with worse outcome in trauma. J Trauma 54: 898–905.
31. Mardel SN, Saunders FM, Allen H et al. 1998. Reduced quality of clot formation with gelatin-based plasma substitutes. Br J Anaesth 80: 204–207.
32. Moore EE, Johnson JL, Cheng AM, Masuno T, Banerjee A. 2005. Insights from studies of blood substitutes in trauma. Shock 24: 197–205.
33. Pascual JL, Khwaja KA, Chaudhury P, Christou NV. 2003. Hypertonic saline and the microcirculation. J Trauma 54(5 Suppl): S133–S140.
34. Ramsay G. 1988. Intravenous volume replacement: indications and choices. Br Med J (Clin Res Ed) 296: 1422–1423.
35. Ring J, Messmer K. 1977. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1: 466–469.
36. Rizoli SB, Kapus A, Fan J, Li YH, Marshall JC, Rotstein OD. 1998. Immunomodulatory effects of hypertonic resuscitation on the development of lung inflammation following hemorrhagic shock. J Immunol 161: 6288–6296.
37. Rizoli SB. 2003. Crystalloids and colloids in trauma resuscitation: a brief overview of the current debate. J Trauma 54(5 Suppl): S82–S88.
38. Roberts I, Alderson P, Bunn F, Chinnock P, Ker K, Schierhout G. 2004. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 4: CD000567-CD000567.
39. Ruttmann TG, James MF, Aronson I. 1998. In vivo investigation into the effects of haemodilution with hydroxyethyl starch (200/0.5) and normal saline on coagulation. Br J Anaesth 80: 612–616.
40. Saddler JM, Horsey PJ. 1987. The new generation gelatins. A review of their history, manufacture and properties. Anaesthesia 42(9): 998–1004.
41. Salmon JB, Mythen MG. 1993. Pharmacology and physiology of colloids. Blood Rev 7: 114–120.
42. Schierhout G, Roberts I. 1998. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. Br Med J 316: 961–964.
43. Shi HP, Deitch EA, Da Xu Z, Lu Q, Hauser CJ. 2002. Hypertonic saline improves intestinal mucosa barrier function and lung injury after trauma-hemorrhagic shock. Shock 17: 496–501.
44. Sloan EP, Koenigsberg M, Gens D et al. 1999. Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial. JAMA 282: 1857–1864.
45. Spahn DR. 1999. Blood substitutes. Artificial oxygen carriers: perfluorocarbon emulsions. Crit Care 3: R93–R97.
46. Tabuchi N, de Haan J, Gallandat Huet RC, Boonstra PW, van Oeveren W. 1995. Gelatin use impairs platelet adhesion during cardiac surgery. Thromb Haemost 74: 1447–1451.
47. Treib J, Haass A, Pindur G, Grauer MT, Wenzel E, Schimrigk K. 1996a. All medium starches are not the same: influence of the degree of hydroxyethyl substitution of hydroxyethyl starch on plasma volume, hemorrheologic conditions, and coagulation. Transfusion 36: 450–455.
48. Treib J, Haass A, Pindur G et al. 1996b. Highly substituted hydroxyethyl starch (HES200/0.62) leads to Type-I von Willebrand syndrome after repeated administration. Haemostasis 26: 210–213.
49. Treib J, Haass A, Pindur G. 1997. Coagulation disorders caused by hydroxyethyl starch. Thromb Haemost 78: 974–983.
50. Velanovich V. 1989. Crystalloid versus colloid fluid resuscitation: a meta-analysis of mortality. Surgery 105: 65–71.
51. Wade CE, Grady JJ, Kramer GC. 2003. Efficacy of hypertonic saline dextran fluid resuscitation for patients with hypotension from penetrating trauma. J Trauma 54(5 Suppl): S144–S148.
52. Watenpaugh DE, Gaffney FA. 1998. Measurement of net whole-body transcapillary fluid transport and effective vascular compliance in humans. J Trauma 45: 1062–1068.
53. Webb AR, Moss RF, Tighe D et al. 1992. A narrow range, medium molecular weight pentastarch reduces structural organ damage in a hyperdynamic porcine model of sepsis. Intensive Care Med 18: 348–355.
54. Wilkes NJ, Woolf R, Mutch M et al. 2001. The effects of balanced versus saline-based hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients. Anesth Analg 93: 811–816.